Replies to post #87700 on Biotech Values

[DewDiligence]

PYMX MNTA:

why couldn't PMX-60056 theoretically be partnered with SNY or, better yet, Sandoz/MNTA?

The commercial benefit of having reversibility data would accrue not only to branded Lovenox, but also to any substitutable generic and vice-versa. Hence, if SNY or NVS sponsored a PMX-60056 program, they would be helping their competitor as much as they would be helping themselves.